Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -22.282% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC(C)[C@H](NC(=O)NC1CCCc2ccccc21)C(=O)O
b CC(C)Cn1c(N)c(C(=O)NCC2CCCO2)c2nc3ccccc3nc21
c COc1ccccc1N1CCN(C(=O)CN(C)S(=O)(=O)c2cc(C)ccc2OC)CC1
Answer: b. CC(C)Cn1c(N)c(C(=O)NCC2CCCO2)c2nc3ccccc3nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Cn1c(N)c(C(=O)NCC2CCCO2)c2nc3ccccc3nc21
CC(C)Cn1c(N)c(C(=O)NCC2CCCO2)c2nc3ccccc3nc21
2-amino-1-(2-methylpropyl)-N-(oxolan-2-ylmethyl)pyrrolo[3,2-b]quinoxaline-3-carboxamide